Health Care & Life Sciences » Pharmaceuticals | Adamas Pharmaceuticals Inc.

Adamas Pharmaceuticals Inc. | Key People and Executives

Gregory T. Went
Chairman & Chief Executive Officer
Mardi C. Dier
Director
John A. MacPhee
Director
Michael F. Bigham
Independent Director
Martha J. Demski
Independent Director
David L. Mahoney
Lead Independent Director
Ivan M. Lieberburg
Independent Director
Bill W. Ericson
Independent Director
Gregory T. Went
Chairman & Chief Executive Officer
Richard A. King
Chief Operating Officer
Alfred G. Merriweather
Chief Financial Officer
Rajiv Patni
Chief Medical Officer
Jennifer J. Rhodes
Secretary, Chief Compliance & Business Officer
Natalie L. McClure
Senior Vice President-Product Development
Mardi C. Dier
Director
John A. MacPhee
Director
Christopher B. Prentiss
Chief Accounting Officer
Ashleigh Barreto
Director-Communications & Investor Relations
Michael F. Bigham
Independent Director
Martha J. Demski
Independent Director
David L. Mahoney
Lead Independent Director
Ivan M. Lieberburg
Independent Director
William W. Ericson
Independent Director

About Adamas Pharmaceuticals

View Profile
Address
1900 Powell Street
Emeryville California 94608
United States
Employees -
Website http://www.adamaspharma.com
Updated 07/08/2019
Adamas Pharmaceuticals, Inc. is a pharmaceutical company, which engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products includes ADS-5012, ADS-4101, and Namenda XR. The ADS-5102 is a treatment for levodopa-induced dyskinesia in patients with Parkinson's disease.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.